Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beam Therapeutics Inc. Director's Dealing 2021

Mar 23, 2021

31533_dirs_2021-03-22_5c4e8714-2a16-4945-aba8-43aa091be94c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-03-18

Reporting Person: ARCH Venture Partners IX, LLC (10% Owner)
Reporting Person: ARCH Venture Partners IX, L.P. (10% Owner)
Reporting Person: ARCH Venture Partners IX Overage, L.P. (10% Owner)
Reporting Person: ARCH Venture Fund IX, L.P. (10% Owner)
Reporting Person: ARCH Venture Fund IX Overage, L.P. (10% Owner)
Reporting Person: CRANDELL KEITH (10% Owner)
Reporting Person: BYBEE CLINTON (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-18 Common Stock J 200000 Disposed 3921520 Indirect
2021-03-18 Common Stock J 200000 Disposed 3921519 Indirect
2021-03-18 Common Stock J 2553 Acquired 2553 Direct
2021-03-18 Common Stock J 810 Acquired 810 Direct
2021-03-22 Common Stock J 200000 Disposed 3721520 Indirect
2021-03-22 Common Stock J 200000 Disposed 3721519 Indirect
2021-03-22 Common Stock J 2555 Acquired 5108 Direct
2021-03-22 Common Stock J 813 Acquired 1623 Direct

Footnotes

F1: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F2: These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.

F3: These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.

F4: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.

F5: Shares held directly by Crandell.

F6: Shares held directly by Bybee.